- Brinton Pharma has been adjudged The Most Admired Pharma Company of the Year & The Emerging Pharma Company of the Year
- Brinton’s Chairman & Managing Director was also awarded as ‘Business Leader of the Year’ at the Pharma Excellence awards
Brinton Pharmaceuticals, India’s fastest growing multinational pharmaceuticals company, won three accolades at Pharma Excellence Awards 2018, reinforcing its fast pacing growth in the Pharma Industry. Brinton Pharmaceuticals was awarded as the ‘Most Admired Pharma Company’ and was also adjudged as ‘The Emerging Pharma company of the Year’. Also, Mr. Rahul Darda, Chairman & Managing Director was awarded as ‘Business Leader’ of the Year’.
Brinton Pharmaceuticals Ltd started its India operations in September 2014 and within a year of its inception became the fastest growing pharmaceutical company in the domain of Dermatology in India. Brinton Paediatric division markets products ranging from paediatric nutrition, respiratory and other therapy areas and are already available in the market. Brinton is currently pursuing a strong R&D to bring more innovative products like paediatric nutrition, probiotics, Juvenile diabetes, paediatric cardiology and many more.
In its award citation, Rahul Darda, Chairman and Managing Director, Brinton Pharmaceuticals, said, ‘We are extremely honoured to receive three accoladed at the beginning of the year by Pharma Excellence Awards 2018 – at World Health and Wellness Congress. The honour gives us a motivation to work towards better products and helps us set an impressive example of innovation, and the company is utilising new technology to establish itself as a leader in the dermatology and Paediatric segment.
On receiving the prestigious recognition, Vijey Christopher, Director – Marketing, Brinton Pharmaceuticals, said, “We are honoured to receive such a prestigious and significant global recognition from the World Health and Wellness Congress. We had invested significantly in technology in our quest to be ahead of the curve regarding Innovative products in Derma and Paediatrics. We feel vindicated having pursued such a strategy. These awards reaffirm Brinton’s mission of breaking technological barriers to provide superior products.”